SEC Form D private-offering filing
FibroBiologics, Inc.
A new SEC Form D private-offering notice from Houston, TX, a $4,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Clinical stage cell therapy company developing fibroblast based treatments for chronic diseases including multiple sclerosis and disc degeneration.
Filed 2025-12-03Filed to raise $4,000,000First money in 2025-11-18Raised so far $4,000,000HQ (as filed) Houston, TXSector Biotech ✓Stage (inferred) SeedCall status Needs classification
Source linked the Form D on EDGAR↗Website verified fibrobiologics.com↗Named in the filing 7 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.